The frequency of major complications among fasting people with diabetes according to risk categories of IDF-DAR guidelines 2016

被引:0
|
作者
Iqbal, Muhammad Danish [1 ]
Askari, Saima [1 ]
Ahmedani, Muhammad Yakoob [1 ]
机构
[1] Baqai Med Univ, Baqai Inst Diabetol & Endocrinol, Dept Med, Karachi, Pakistan
来源
关键词
Diabetes; Complications; Ramadan; Risk categories; CHRONIC KIDNEY-DISEASE; MUSLIM PATIENTS; RAMADAN; INSULIN; GLICLAZIDE; VILDAGLIPTIN; EDUCATION; MELLITUS;
D O I
10.1016/j.cegh.2020.03.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim/background: To determine the frequency of major complications among fasting people with diabetes according to risk categories of IDF-DAR guidelines 2016. Methods: This prospective observational study was conducted around Ramadan of 2017, at Baqai Institute of Diabetology and Endocrinology, Karachi, Pakistan. People with diabetes having intention to fast during Ramadan were recruited. Demographic data collection along with risk categorization was done during pre-Ramadan visit. Structured education was given on one to one basis to each of the study participants. Assessment of complications was made during post Ramadan visit. Results: There were 131 participants in this study. Mean age was 53.77 +/- 12.67 years. Sixty three percent were males. 4.58% were of type 1 diabetes while 95.41 were of type 2 diabetes. Mean duration of diabetes was 9.92 +/- 7.752 years and mean HbA1c was 8.711 +/- 1.878. Major hypoglycemia occurred in 31.2% of very high-risk category only. None of the high risk and moderate/low risk categories had major hypoglycemia. There was no major hyperglycemia noted in any of the categories of patients. 50% of very high risk and 3.3% of high-risk category required breaking of fast. None of the participants required hospitalization. Conclusion: In this prospective study, majority of fasting people with diabetes fall into high risk category and did not develop major complications. Very high-risk category had highest number of complications while low to moderate category develop none. Further large-scale studies are needed to validate our finding.
引用
收藏
页码:958 / 961
页数:4
相关论文
共 8 条
  • [1] Evidence-based risk factors for major complications during Ramadan fasting in people with diabetes grouped under IDF-DAR risk categories
    Rahmatullah
    Ahmedani, Muhammad Yakoob
    Basit, Abdul
    Zia, Shagufta
    Hasan, Imran
    Masroor, Qazi
    Shaikh, Abrar
    Khan, Jehangir
    Iqbal, Waheed
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185
  • [2] Clinical validity of IDF-DAR risk score among fasting people with diabetes during Ramadan
    Yousuf, S.
    Ahmedani, M. Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [3] Clinical validity of International Diabetes Federation, Diabetes and Ramadan (IDF-DAR) risk score among fasting people with diabetes during Ramadan
    Yousuf
    Ahmedani
    DIABETIC MEDICINE, 2023, 40
  • [4] Validation of the new IDF-DAR risk assessment tool for Ramadan fasting in patients with diabetes
    Mohammed, Nagi
    Buckley, Adam
    Siddiqui, Mohsin
    Al Ahmed, Sameera
    Afandi, Bachar
    Hassanein, Mohamed
    Lessan, Nader
    Suliman, Mohamed
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (04)
  • [5] Risk factors associated with fasting during Ramadan among individuals with diabetes according to IDF-DAR risk score in Atbara city, Sudan: Cross-sectional hospital-based study
    Noor, Sufian K.
    Alutol, Mo'min T.
    FadAllah, FadAllah S. A.
    Ahmed, Ahmed A.
    Osman, Sohep A.
    Badi, Safaa
    Fathelrahman, Ahmed Ibrahim
    Ahmed, Musaab
    Ahmed, Mohamed H.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (03)
  • [6] Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study
    Kamrul-Hasan, A. B. M.
    Alam, Muhammad Shah
    Kabir, Md. Ahamedul
    Chowdhury, Sumon Rahman
    Hannan, Muhammad Abdul
    Chowdhury, Emran Ur Rashid
    Ahsan, Md. Mainul
    Mohana, Choman Abdullah
    Iftekhar, Mohammad Hasan
    Hasan, Mohammad Jahid
    Talukder, Samir Kumar
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2023, 31
  • [7] Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study
    Shamsi, Najla
    Naser, Jameel
    Humaidan, Hanan
    Al-Saweer, Abeer
    Jaafar, Masooma
    Abbas, Fadheela
    Al-Doseri, Sumaya
    Shabeeb, Najat
    Al-Shaikh, Ebtihaj
    Al-Dairi, Abdulrasool
    Mandoos, Khawla
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 211
  • [8] Changing how we risk-categorise in Ramadan: Does the IDF-DAR scoring system achieve the requirements for people with diabetes internationally?
    Ghouri, Nazim
    Hussain, Sufyan
    Ahmed, Syed H.
    Beshyah, Salem A.
    Rashid, Rafaqat
    Al-Ozairi, Ebaa
    Waqar, Salman
    Dabhad, Ammarah
    Mohammed, Ruzwan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 175